Fund Research

The Cost To Perform A Randomized Controlled Trial Is $720,000 US Dollars.
Seeking FDA Clearance

Before NET Recovery can make NET devices available for service in the United States, we need market clearance from the U.S. Food & Drug Administration (FDA). The next step towards reaching that goal is to conduct a randomized controlled trial (RCT). The cost of this critical research is estimated to be $720,000. Simply put, we need your help to overcome this financial hurdle. With your help, we can start the clinical study by the end of 2020.

Donate & Join Our Grassroots Movement!

Your generous gift will help to enable us to conduct a Randomized Controlled Trial (RCT), the results of which NET Recovery plans to submit to the FDA in support of an application for market clearance (or approval) for the NET Model 901 neuro-stimulation device.  Donations are not tax-deductible at this time, although we hope to be able to offer deductible giving options in the future. Your generosity helps us to reach our goal of moving to the next critical phase in our mission. Please send your gift using the form that will load below.

 
  • Facebook
  • Twitter
  • Instagram

The NET Model 901 medical device is approved for usage in the United Kingdom and European Union. In the United States, the NET Model 901 is available for use as an Investigational Device only.

© 2020 NET Recovery